ENLIVEN THERAPEUTICS, INC. (ELVN)

SEC filing

ENLIVEN THERAPEUTICS, INC.

ELVN · CIK 1672619

4 · Mar 11, 2026 · Collins Helen Louise sold 40K shares at $30.07/share ($1.2M); exercised options for 40K shares

Collins Helen Louise sold 40K shares at $30.07/share ($1.2M); exercised options for 40K shares

xslF345X05/form4-03112026_090319.xml

xslF345X05/form4-03112026_090319.xmlSEC.gov

Graphics and non-inline formats (not embedded below).